Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection.

Journal: JGH open : an open access journal of gastroenterology and hepatology
Published Date: Dec 23, 2019

Abstract

BACKGROUND AND AIMS: This study aimed to clarify the clinical picture of hepatitis C virus (HCV) carriers with normal alanine aminotransferase (CNALT) and those with ALT elevation (non-CNALT) under direct-acting antivirals (DAAs).

Authors

  • Satoru Joshita
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Ayumi Sugiura
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Takeji Umemura
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Tomoo Yamazaki
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Naoyuki Fujimori
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Akihiro Matsumoto
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.
  • Yoko Usami
    Department of Laboratory Medicine Shinshu University Hospital Matsumoto Japan.
  • Eiji Tanaka
    Department of Medicine, Division of Gastroenterology and Hepatology Shinshu University School of Medicine Matsumoto Japan.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals